RGNT - REGENTIS BIOMATERIALS LTD.

6.65
0   0%

Share volume: 1,623
Last Updated: 12-24-2025
Pharmaceutical Products/Pharmaceutical Preparations: -0.11%

PREVIOUS CLOSE
CHG
CHG%
$6.65
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
0%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 0%
Performance
5 Days
0   0%
1 Month
-11.33%
3 Months
-11.33%
6 Months
-11.33%
1 Year
-11.33%
2 Year
-11.33%
Key data
Stock price
$6.65
P/E Ratio 
N/A
DAY RANGE
$6.50 - $6.65
EPS 
N/A
52 WEEK RANGE
$5.75 - $7.70
52 WEEK CHANGE
-$11.33
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$15,476
AVERAGE 30 VOLUME 
$37,986
Company detail
CEO: Eli Hazum
Region: US
Website: www.regentis.co.il/
Employees: 10
IPO year: 2025
Issue type:
Market: NYSE American
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

We are a regenerative medicine company dedicated to developing innovative tissue repair solutions that seek to restore the health and enhance the quality of life of patients. Regentis Biomaterials LTD is located in Herzliya, Israel.

Recent news